Tags : Name

Depomed changes name to Assertio Therapeutics

Shots: Depomed changes name to Assertio Therapeutics on Aug 15, 2018, with a strategic focus on our neurology, orphan and specialty medicines The rebranding is done after Senate committee opened probe for opioid marketing last year Assertio’s common stock has started trading with new ticker “ASRT” from Aug 15, 2018. Depomed also completed the relocation […]Read More